Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Cui Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3779-0424; OpenAlex author ID A5029026275. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 5

  1. Close, But no Cigar: Comparative Evaluation of ChatGPT-4o and OpenAI o1-preview in Answering Pancreatic Ductal Adenocarcinoma-Related Questions Last author DOI 10.1101/2025.07.26.25332239↗
  2. Punching Above Its Weight: A Head-to-Head Comparison of Deepseek-R1 and OpenAI-o1 on Pancreatic Adenocarcinoma-Related Questions. Last author DOI 10.7150/ijms.118887↗
  3. GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer. Co-author DOI 10.3390/cancers12123774↗
  4. Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer. Co-author DOI 10.3390/diagnostics10050305↗
  5. Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection. Co-author DOI 10.18632/oncotarget.20315↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christoph Reißfelder · 4 shared papers, 2017–2025 · strength 0.59
  2. Chengpeng Li · 2 shared papers, 2025 · strength 0.54
  3. Sebastian Schölch · 3 shared papers, 2017–2020 · strength 0.31
  4. Dao-Ning Liu · 1 shared paper, 2025 · strength 0.26
  5. Lei Zhu · 2 shared papers, 2020 · strength 0.24
  6. Balázs Győrffy · 2 shared papers, 2020 · strength 0.24
  7. Sonja Loges · 1 shared paper, 2020 · strength 0.11
  8. Nuh N. Rahbari · 1 shared paper, 2017 · strength 0.07
  9. Christoph Kahlert · 1 shared paper, 2017 · strength 0.07
  10. Jürgen Weitz · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.